Literature DB >> 10735416

Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults.

J Grünenfelder1, G Zünd, A Schoeberlein, F E Maly, U Schurr, S Guntli, K Fischer, M Turina.   

Abstract

OBJECTIVE: Cardiac surgery with cardiopulmonary bypass (CPB) results in expression of cytokines and adhesion molecules (AM) with subsequent inflammatory response. The purpose of the study was to evaluate the clinical impact of modified ultrafiltration (MUF) and its efficacy in reducing cytokines and AM following coronary artery bypass grafting (CABG) in adults.
METHODS: A prospective randomized study of 97 patients undergoing elective CABG was designed. Fifty patients were operated on using normothermic and 47 patients using hypothermic CPB. The normothermic group was subdivided into a group with modified ultrafiltration (n = 30) and a group without MUF (n = 20). In the hypothermic group 30 patients received MUF compared to 17 patients serving as controls. MUF was instituted after CPB for 15 min through the arterial and venous bypass circuit lines. Cytokines (IL-6, IL-8, TNF-alpha, IL-2R) and adhesion molecules (sE-selectin, sICAM-1) were measured preoperatively, pre-MUF, in the ultrafiltrate, 24 h, 48 h and 6 days after surgery by chemiluminescent enzyme immunometric assay or enzyme-linked immunosorbent assay (ELISA). Clinical parameters were collected prospectively until discharge.
RESULTS: In all patients AM and cytokines were significantly elevated after normothermic and hypothemic CPB. AM and cytokines were significantly higher in hypothermia compared to normothermia. In hypothermic CPB sE-selectin was decreased after 24 h by 37% (P < 0.0063) and by 40% (P < 0.0027) after 48 h postoperatively. ICAM-1 was reduced by 43% (P < 0.0001) after 24 h and by 60% (P < 0.0001) after 6 days. Similar results were seen in cytokines with reduction up to 60% after 24 h. Changes after 48 h were noticeable but not significant. Reduction of AM and cytokines after normothermic CPB was minimal. Neither in normothermia, nor in hypothermia has sIL-2R been effectively removed from the circulation. There were no significant differences in the clinical variables between the patients with or without MUF.
CONCLUSION: AM and cytokines are significantly elevated after hypothermic CPB compared to normothermic CPB. MUF led to a significant reduction in cytokine and AM levels after hypothermic CPB, except for IL-2R. MUF showed minimal effect in normothermia. We conclude that MUF is an efficient way to remove cytokines and AM. However, we were unable to demonstrate any significant impact of MUF in outcome of adults after elective CABG.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735416     DOI: 10.1016/s1010-7940(99)00355-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Benefits of early haemofiltration during aorto-bifemural bypass with mesenteric revascularization - a case report.

Authors:  Gabriel Gheorghiu; Diana Benteu; Claudiu Neamţu; Raluca Boieru; Georgel Ţăranu; Dorel Săndesc
Journal:  Rom J Anaesth Intensive Care       Date:  2015-04

2.  A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery.

Authors:  J Trent Magruder; Todd C Crawford; Herbert Lynn Harness; Joshua C Grimm; Alejandro Suarez-Pierre; Chad Wierschke; Jim Biewer; Charles Hogue; Glenn R Whitman; Ashish S Shah; Viachaslau Barodka
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-19       Impact factor: 5.209

3.  Administration of steroids in pediatric cardiac surgery: impact on clinical outcome and systemic inflammatory response.

Authors:  P Gessler; V Hohl; T Carrel; J Pfenninger; E R Schmid; O Baenziger; R Prètre
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

4.  Relationship between increased blood pressure and hematocrit during modified ultrafiltration for pediatric open heart surgery.

Authors:  Shin Takabayashi; Hideto Shimpo; Kazuto Yokoyama; Hideki Iwata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-01

5.  Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.

Authors:  Elettra C Poli; Lorenzo Alberio; Anna Bauer-Doerries; Carlo Marcucci; Aurélien Roumy; Matthias Kirsch; Eleonora De Stefano; Lucas Liaudet; Antoine G Schneider
Journal:  Crit Care       Date:  2019-04-03       Impact factor: 9.097

6.  Ultrafiltration attenuates cardiopulmonary bypass-induced acute lung injury in a canine model of single-lung transplantation.

Authors:  Masayuki Saitoh; Masanori Tsuchida; Terumoto Koike; Koichi Satoh; Manabu Haga; Tadashi Aoki; Shin-ichi Toyabe; Jun-ichi Hayashi
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

7.  Comparison of Custodiol vs warm blood cardioplegia and conditioning of donor hearts during transportation with the organ care system.

Authors:  Rymbay Kaliyev; Timur Lesbekov; Serik Bekbossynov; Makhabbat Bekbossynova; Zhuldyz Nurmykhametova; Svetlana Novikova; Nurlan Smagulov; Assel Medressova; Linar Faizov; Zhanibek Ashyrov; Philip la Fleur; Robertas Samalavicius; Yuriy Pya
Journal:  J Card Surg       Date:  2019-07-23       Impact factor: 1.620

8.  Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Zhao Kai Low; Fei Gao; Kenny Yoong Kong Sin; Kok Hooi Yap
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

9.  Cox-Maze III procedure with valvular surgery in an autopneumonectomized patient.

Authors:  Jin Hong Wi; Ho-Ki Min; Do Kyun Kang; Hee Jae Jun; Youn-Ho Hwang; Dong-Kie Kim; Hyun Kuk Kim; Hang Jea Jang; Il Rhee
Journal:  J Cardiothorac Surg       Date:  2012-11-08       Impact factor: 1.637

10.  High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study.

Authors:  Ka-Young Rhee; Tae-Yun Sung; Ju Deok Kim; Hyun Kang; Nazri Mohamad; Tae-Yop Kim
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.